BridgeBio Pharma Inc (BBIO)
NASDAQ:BBIO

BridgeBio Pharma (BBIO) Financial Statements

878 Followers

BridgeBio Pharma Financial Overview

BridgeBio Pharma's market cap is currently ―. The company's EPS TTM is $-3.228; its P/E ratio is -8.27; BridgeBio Pharma is scheduled to report earnings on August 1, 2024, and the estimated EPS forecast is $-1.00. See an overview of income statement, balance sheet, and cash flow financials.
Mar 24Dec 23Sep 23Jun 23Mar 23
Income Statement-
Total Revenue$ 211.12M$ 1.75M$ 4.09M$ 1.64M$ 1.83M
Gross Profit$ 210.52M$ 1.15M$ 3.49M$ 1.64M$ 1.18M
EBIT$ -12.69M$ -150.06M$ -151.54M$ -132.47M$ -130.25M
EBITDA$ -11.09M$ -148.47M-$ -130.83M$ -128.62M
Net Income Common Stockholders$ -35.22M$ -168.15M$ -177.00M$ -157.90M$ -140.16M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 519.69M$ 434.88M$ 543.26M$ 403.72M$ 516.80M
Total Assets$ 849.33M$ 546.38M$ 655.01M$ 503.66M$ 625.68M
Total Debt$ 447.56M$ 459.55M$ 455.67M$ 455.19M$ 451.34M
Net Debt$ -72.13M$ 24.67M$ -87.59M$ 51.46M$ -65.45M
Total Liabilities$ 1.89B$ 1.89B$ 1.85B$ 1.85B$ 1.84B
Stockholders Equity$ -1.05B$ -1.35B$ -1.21B$ -1.36B$ -1.23B
Cash Flow-
Free Cash Flow$ -221.03M$ -125.25M-$ -113.78M$ -144.33M
Operating Cash Flow$ -219.54M$ -124.82M$ -145.23M$ -113.35M$ -144.32M
Investing Cash Flow$ 22.75M$ -66.00K$ 37.68M$ 4.12M$ 12.30M
Financing Cash Flow$ 279.55M$ -4.52M$ 307.04M$ -1.23M$ 150.25M
Currency in USD

BridgeBio Pharma Earnings and Revenue History

BridgeBio Pharma Debt to Assets

BridgeBio Pharma Cash Flow

BridgeBio Pharma Forecast EPS vs Actual EPS

What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis